Table 2.
Main outcome indices and measures across the study phases.
Main outcome indices and measures | Screen | Baseline | Mid- | Post- and Follow-up |
---|---|---|---|---|
Initial screening and study eligibility | ||||
Phone screen protocol (incl. medical comorbidities) | x | |||
Depression (BDI-FS) | x | |||
Anxiety (GAD-7) | x | |||
Inclusion/exclusion criteria | ||||
SCID assessment (incl. psychiatric comorbidities) | x | |||
Sociodemographic data | x | |||
Online questionnaires | ||||
Exercise related measures | ||||
Physical activity levels | x | x | x | |
Exercise readiness | x | x | ||
Exercise self-efficacy and barriers (ESES; BARSE) | x | x | ||
Confidence and support for exercise (SSES) | x | x | ||
Program and outcome expectations | x | x | ||
Resolve | x | x (Wk4 & 8) | x | |
Sedentary behaviour (Sitting Time Questionnaire) | x | x | ||
Psychological functioning measures | ||||
Self-esteem (SISE) | x | x | ||
Eating disorder behaviours (EDE-Q) | x | x | ||
Quality of life and (Q-LES-Q-SF) | x | x | ||
Life satisfaction (SWLS) | x | x | ||
Physical self-concept and physique anxiety (PSDQ-S; SPAS) | x | x | ||
Alcohol and other drug use (AUDIT) | x | x | ||
Psychological assessment | ||||
Depression and associated factors | ||||
SCID assessment for current MDD | x | x | ||
Depression severity (BDI-II) | x | x | x | |
Anxiety (BAI) | x | x | ||
Cognitive changes (ATQ; DASF1 & DASF2) | x | x | x | |
Behavioural activation (BADS-SF) | x | x | x | |
Somatic symptoms (DSSS; PHQ-15) | x | x | x | |
Physical fitness and physiological assessments | ||||
Exercise and Sports Science Australia (ESSA) screen | x | x | ||
Sedentary behaviour (Sitting Time Questionnaire) | x | x | ||
Exercise history | x | x | ||
Developmental maturation | x | x | ||
Maximal aerobic capacity | x | x | ||
Muscular strength endurance | x | x | ||
Anthropometrics (e.g., BMI, body composition) | x | x | ||
Biological markers | ||||
IL6, BDNF, blood samples stored | x | x |